Michael Colrus - Scibase AB Chief Officer

All Insiders . Sweden . 
Stock . Scibase AB . Stakeholders . Insider . Michael Colrus
SCIB Stock  SEK 0.39  0.04  11.43%   

Insider

Michael Colrus is Chief Officer of Scibase AB
Age 61
Phone46 8 41 06 20 00
Webhttps://www.scibase.com

Scibase AB Management Efficiency

The company has return on total asset (ROA) of (0.4288) % which means that it has lost $0.4288 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8992) %, meaning that it generated substantial loss on money invested by shareholders. Scibase AB's management efficiency ratios could be used to measure how well Scibase AB manages its routine affairs as well as how well it operates its assets and liabilities.
Scibase AB has accumulated 356 K in total debt. Scibase AB has a current ratio of 5.61, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Scibase AB until it has trouble settling it off, either with new capital or with free cash flow. So, Scibase AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Scibase AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Scibase to invest in growth at high rates of return. When we think about Scibase AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Beata LihammarEpisurf Medical AB
N/A
Thoas MDCantargia AB
61
Susanne LagerlundCantargia AB
N/A
Helen RoundAcarix AS
59
Anette LindqvistXbrane Biopharma AB
57
Stephen CaswellEpisurf Medical AB
42
Tobias FritzAcarix AS
44
Adnan DeronicCantargia AB
N/A
Nina ValkamaCantargia AB
N/A
Samuel WagnerXbrane Biopharma AB
N/A
Marianne NorskovAcarix AS
45
Patrick JamnikEpisurf Medical AB
40
Thomas LundstrmAcarix AS
49
Anders KrabbeAcarix AS
56
Kjell SjstrmCantargia AB
N/A
MarcussCantargia AB
N/A
Nina IversXbrane Biopharma AB
53
Erik DominesXbrane Biopharma AB
59
Christian LindholmAcarix AS
59
Katarina FlodstrmEpisurf Medical AB
48
Ignacio GarciaRibasCantargia AB
N/A
SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company was founded in 1998 and is headquartered in Stockholm, Sweden. Scibase Holding operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people. Scibase AB (SCIB) is traded on Stockholm Exchange in Sweden and employs 21 people.

Management Performance

Return On Equity-0.9
Return On Asset-0.43

Scibase AB Leadership Team

Elected by the shareholders, the Scibase AB's board of directors comprises two types of representatives: Scibase AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scibase. The board's role is to monitor Scibase AB's management team and ensure that shareholders' interests are well served. Scibase AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scibase AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stig Ollmar, Founder, Chief Scientific Officer, Director, Inventor
Tobias Bergenblad, Global Sales Manager
Simon Grant, CEO Pres
Per Svedenhag, Head of Business Development and Marketing
Michael Colrus, Chief Officer
Linn Olsen, Head Production

Scibase Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scibase AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.9
Return On Asset-0.43
Profit Margin(2.41) %
Operating Margin(2.59) %
Current Valuation208.42 M
Shares Outstanding68.48 M
Shares Owned By Insiders26.42 %
Shares Owned By Institutions16.44 %
Price To Earning(2.75) X
Price To Book7.00 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Scibase Stock Analysis

When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY